GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Capex-to-Operating-Income

Universal Ibogaine (TSXV:IBO) Capex-to-Operating-Income : 0.00 (As of Apr. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Universal Ibogaine's Capital Expenditure for the three months ended in Apr. 2024 was C$-0.02 Mil. Its Operating Income for the three months ended in Apr. 2024 was C$-0.43 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Universal Ibogaine Capex-to-Operating-Income Historical Data

The historical data trend for Universal Ibogaine's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Capex-to-Operating-Income Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

Universal Ibogaine Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Universal Ibogaine's Capex-to-Operating-Income

For the Biotechnology subindustry, Universal Ibogaine's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Capex-to-Operating-Income falls into.



Universal Ibogaine Capex-to-Operating-Income Calculation

Universal Ibogaine's Capex-to-Operating-Income for the fiscal year that ended in Jul. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.36) / -2.051
=N/A

Universal Ibogaine's Capex-to-Operating-Income for the quarter that ended in Apr. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.019) / -0.434
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Universal Ibogaine  (TSXV:IBO) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Universal Ibogaine Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine Business Description

Traded in Other Exchanges
Address
815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine Headlines